Unraveling Healthcare Data Bias

This chapter examines the intricate biases present in data released by agencies like the CDC and FDA, highlighting financial influences from pharmaceutical companies. It reflects on how these biases can skew public perception of drug effectiveness and the implications for medical practices. The conversation advocates for a critical evaluation of data sources within the healthcare landscape, emphasizing the urgent need for reform in American healthcare policies.